查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1663414

全球不孕指标市场规模研究（按类型、按技术、按最终用途）及区域预测 2022-2032

Global Sterility Indicators Market Size Study, by Type, by Technique, by End Use, and Regional Forecasts 2022-2032
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 285 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年全球不孕指标市场价值约为 10.2 亿美元，预计在 2024-2032 年预测期内将以 10.9% 的强劲复合年增长率成长。这一成长的推动因素是，医疗机构越来越多地采用无菌操作，以及全球对感染控制措施的需求不断增长。随着外科手术和医院内感染 (HAI) 的不断增加，对可靠的灭菌工艺和无菌保证产品的需求显着增加。

无菌指示剂包括化学和生物类型，在验证灭菌方法的有效性方面发挥关键作用，确保医疗器材、药品和实验室设备不受微生物污染。 FDA 和 EMA 等监管机构实施了严格的灭菌标准，推动了这些指标在医疗保健和製药行业的采用。此外，技术进步提高了无菌指标的可靠性、灵敏度和易用性，进一步支持了其市场扩张。

由于外科和一般病人照护环境中的消毒要求很高，因此医院部门在市场中占据主导地位。同时，由于研发活动的增加和药品生产无菌保证的监管要求，製药业预计将实现最快的成长。区域成长由北美引领，得益于其先进的医疗基础设施和较高的感染控制标准，而亚太地区则由于医疗保健管道的扩大和对消毒技术的投资而成为成长最快的地区。

市场的详细细分和子细分如下：

目录

第 1 章：全球不孕指标市场执行摘要

  • 全球不孕症指标市场规模及预测（2022-2032 年）
  • 区域概况
  • 节段概要
    • 按类型
    • 依技术分类
    • 按最终用途
  • 主要趋势
  • 经济衰退的影响
  • 分析师建议与结论

第 2 章：全球不孕指标市场定义与研究假设

  • 研究目标
  • 市场定义
  • 研究假设
    • 包容与排斥
    • 限制
    • 供给侧分析
      • 可用性
      • 基础设施
      • 监管环境
      • 市场竞争
      • 经济可行性（消费者的观点）
    • 需求面分析
      • 监理框架
      • 技术进步
      • 环境考虑
      • 消费者认知与接受度
  • 估算方法
  • 研究考虑的年份
  • 货币兑换率

第三章：全球不孕指标市场动态

  • 市场驱动因素
    • 医院内感染（HAI）盛行率不断上升
    • 增加外科手术和医疗器械的使用
    • 灭菌过程的严格监管要求
  • 市场挑战
    • 先进灭菌技术成本高昂
    • 发展中地区采用技术的限制
  • 市场机会
    • 不孕指示剂的技术创新
    • 新兴市场需求不断成长
    • 扩大医疗基础设施

第 4 章：全球不孕指标市场产业分析

  • 波特五力模型
    • 供应商的议价能力
    • 买家的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手
    • 波特五力影响分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会的
    • 科技
    • 环境的
    • 合法的
  • 最佳投资机会
  • 最佳获胜策略
  • 颠覆性趋势
  • 产业专家观点
  • 分析师建议与结论

第 5 章：全球不孕指标市场规模与预测：按类型（2022-2032 年）

  • 细分仪表板
  • 全球不孕指标市场：按类型分類的收入趋势分析，2022 年和 2032 年（百万美元/十亿美元）
    • 化学指示剂
      • 1 类
      • 2 级
      • 第 3 类
      • 4 类
      • 第五类
    • 生物指标
      • 孢子安瓿
      • 孢子悬浮液
      • 自备小瓶
      • 孢子条

第 6 章：全球不孕指标市场规模与预测：按技术分类（2022-2032 年）

  • 细分仪表板
  • 全球不孕指标市场：以技术收入趋势分析，2022 年和 2032 年（百万美元/十亿美元）
    • 热灭菌
    • 低温灭菌
    • 过滤除菌
    • 辐射灭菌
    • 液体灭菌

第 7 章：全球不孕指标市场规模与预测：依最终用途（2022-2032 年）

  • 细分仪表板
  • 全球无菌指标市场：以最终用途收入趋势分析，2022 年和 2032 年（百万美元/十亿美元）
    • 医院
    • 製药公司
    • 医疗器材公司
    • 临床实验室/研究中心
    • 其他的

第 8 章：全球不孕指标市场规模与预测：按地区（2022-2032 年）

  • 北美不孕指标市场
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲不孕指标市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太不孕指标市场
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲不孕指标市场
    • 巴西
    • 阿根廷
  • 中东和非洲 (MEA) 不孕指标市场
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 科威特

第 9 章：竞争情报

  • 重点公司 SWOT 分析
    • Getinge
    • STERIS
    • 3M
  • 顶级市场策略
  • 公司简介
    • Getinge
    • STERIS
    • 3M
    • Cardinal Health
    • MATACHANA Group
    • Mesa Labs, Inc.
    • Andersen Sterilizers
    • PMS Healthcare Technologies
    • Propper Manufacturing Co., Inc.
    • Liofilchem Srl

第 10 章：研究过程

  • 研究进程
    • 资料探勘
    • 分析
    • 市场评估
    • 验证
    • 出版
  • 研究属性
简介目录

The global sterility indicators market was valued at approximately USD 1.02 billion in 2023 and is expected to grow at a robust CAGR of 10.9% during the forecast period 2024-2032. This growth is driven by the increasing adoption of sterile practices across healthcare facilities and the growing need for infection control measures worldwide. As surgical procedures and hospital-acquired infections (HAIs) continue to rise, the demand for reliable sterilization processes and sterility assurance products has significantly increased.

Sterility indicators, comprising chemical and biological types, play a critical role in verifying the efficacy of sterilization methods, ensuring that medical devices, pharmaceutical products, and laboratory equipment remain free from microbial contamination. Regulatory bodies such as the FDA and EMA impose stringent sterilization standards, boosting the adoption of these indicators across healthcare and pharmaceutical industries. Moreover, technological advancements have enhanced the reliability, sensitivity, and ease of use of sterility indicators, further supporting their market expansion.

The hospital segment dominates the market owing to the high volume of sterilization requirements in surgical and general patient care settings. Simultaneously, the pharmaceutical sector is projected to register the fastest growth due to increasing R&D activities and regulatory mandates for sterility assurance in drug manufacturing. Regional growth is led by North America, driven by its advanced healthcare infrastructure and high infection control standards, while Asia Pacific emerges as the fastest-growing region due to expanding healthcare access and investments in sterilization technologies.

Major market players included in this report are:

  • Getinge
  • STERIS
  • 3M
  • Cardinal Health
  • MATACHANA Group
  • Mesa Labs, Inc.
  • Andersen Sterilizers
  • PMS Healthcare Technologies
  • Propper Manufacturing Co., Inc.
  • Liofilchem S.r.l.

The detailed segments and sub-segments of the market are explained below:

By Type:

  • Chemical Indicators
    • Class 1
    • Class 2
    • Class 3
    • Class 4
    • Class 5
  • Biological Indicators
    • Spore Ampoules
    • Spore Suspensions
    • Self-contained Vials
    • Spore Strips

By Technique:

  • Heat Sterilization
  • Low-Temperature Sterilization
  • Filtration Sterilization
  • Radiation Sterilization
  • Liquid Sterilization

By End Use:

  • Hospitals
  • Pharmaceutical Companies
  • Medical Device Companies
  • Clinical Laboratories/Research Centers
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Years considered for the study are as follows:

  • Historical Year: 2022
  • Base Year: 2023
  • Forecast Period: 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecasts for 10 years from 2022 to 2032.
  • Annualized revenues and regional-level analysis for each market segment.
  • Detailed analysis of the geographical landscape with country-level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations for future market approaches.
  • Analysis of the competitive structure of the market.
  • Demand-side and supply-side analysis of the market.

Table of Contents

Chapter 1. Global Sterility Indicators Market Executive Summary

  • 1.1. Global Sterility Indicators Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Type
    • 1.3.2. By Technique
    • 1.3.3. By End Use
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Sterility Indicators Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Sterility Indicators Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising Prevalence of Healthcare-Associated Infections (HAIs)
    • 3.1.2. Increasing Surgical Procedures and Use of Medical Devices
    • 3.1.3. Stringent Regulatory Requirements for Sterilization Processes
  • 3.2. Market Challenges
    • 3.2.1. High Costs Associated with Advanced Sterilization Techniques
    • 3.2.2. Limitations in Adopting Technology in Developing Regions
  • 3.3. Market Opportunities
    • 3.3.1. Technological Innovations in Sterility Indicators
    • 3.3.2. Growing Demand in Emerging Markets
    • 3.3.3. Expanding Healthcare Infrastructure

Chapter 4. Global Sterility Indicators Market Industry Analysis

  • 4.1. Porter's Five Forces Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Porter's Five Forces Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunities
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Sterility Indicators Market Size & Forecasts by Type (2022-2032)

  • 5.1. Segment Dashboard
  • 5.2. Global Sterility Indicators Market: By Type Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
    • 5.2.1. Chemical Indicators
      • 5.2.1.1. Class 1
      • 5.2.1.2. Class 2
      • 5.2.1.3. Class 3
      • 5.2.1.4. Class 4
      • 5.2.1.5. Class 5
    • 5.2.2. Biological Indicators
      • 5.2.2.1. Spore Ampoules
      • 5.2.2.2. Spore Suspensions
      • 5.2.2.3. Self-Contained Vials
      • 5.2.2.4. Spore Strips

Chapter 6. Global Sterility Indicators Market Size & Forecasts by Technique (2022-2032)

  • 6.1. Segment Dashboard
  • 6.2. Global Sterility Indicators Market: By Technique Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
    • 6.2.1. Heat Sterilization
    • 6.2.2. Low-Temperature Sterilization
    • 6.2.3. Filtration Sterilization
    • 6.2.4. Radiation Sterilization
    • 6.2.5. Liquid Sterilization

Chapter 7. Global Sterility Indicators Market Size & Forecasts by End Use (2022-2032)

  • 7.1. Segment Dashboard
  • 7.2. Global Sterility Indicators Market: By End Use Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
    • 7.2.1. Hospitals
    • 7.2.2. Pharmaceutical Companies
    • 7.2.3. Medical Device Companies
    • 7.2.4. Clinical Laboratories/Research Centers
    • 7.2.5. Others

Chapter 8. Global Sterility Indicators Market Size & Forecasts by Region (2022-2032)

  • 8.1. North America Sterility Indicators Market
    • 8.1.1. U.S.
    • 8.1.2. Canada
    • 8.1.3. Mexico
  • 8.2. Europe Sterility Indicators Market
    • 8.2.1. U.K.
    • 8.2.2. Germany
    • 8.2.3. France
    • 8.2.4. Italy
    • 8.2.5. Spain
    • 8.2.6. Denmark
    • 8.2.7. Sweden
    • 8.2.8. Norway
  • 8.3. Asia Pacific Sterility Indicators Market
    • 8.3.1. Japan
    • 8.3.2. China
    • 8.3.3. India
    • 8.3.4. Australia
    • 8.3.5. South Korea
    • 8.3.6. Thailand
  • 8.4. Latin America Sterility Indicators Market
    • 8.4.1. Brazil
    • 8.4.2. Argentina
  • 8.5. Middle East & Africa (MEA) Sterility Indicators Market
    • 8.5.1. South Africa
    • 8.5.2. Saudi Arabia
    • 8.5.3. UAE
    • 8.5.4. Kuwait

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Getinge
    • 9.1.2. STERIS
    • 9.1.3. 3M
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Getinge
    • 9.3.2. STERIS
    • 9.3.3. 3M
    • 9.3.4. Cardinal Health
    • 9.3.5. MATACHANA Group
    • 9.3.6. Mesa Labs, Inc.
    • 9.3.7. Andersen Sterilizers
    • 9.3.8. PMS Healthcare Technologies
    • 9.3.9. Propper Manufacturing Co., Inc.
    • 9.3.10. Liofilchem S.r.l.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes